Cargando…
Regulation of Programmed Death Ligand 1 (PD-L1) Expression in Breast Cancer Cell Lines In Vitro and in Immunodeficient and Humanized Tumor Mice
Programmed death ligand 1 (PD-L1) expression is an efficient strategy of tumor cells to escape immunological eradiation. However, only little is known about the factors that affect the cellular expression levels. Here we assessed the PD-L1 expression on different breast cancer cell lines under stand...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855785/ https://www.ncbi.nlm.nih.gov/pubmed/29438316 http://dx.doi.org/10.3390/ijms19020563 |
_version_ | 1783307178355982336 |
---|---|
author | Rom-Jurek, Eva-Maria Kirchhammer, Nicole Ugocsai, Peter Ortmann, Olaf Wege, Anja K. Brockhoff, Gero |
author_facet | Rom-Jurek, Eva-Maria Kirchhammer, Nicole Ugocsai, Peter Ortmann, Olaf Wege, Anja K. Brockhoff, Gero |
author_sort | Rom-Jurek, Eva-Maria |
collection | PubMed |
description | Programmed death ligand 1 (PD-L1) expression is an efficient strategy of tumor cells to escape immunological eradiation. However, only little is known about the factors that affect the cellular expression levels. Here we assessed the PD-L1 expression on different breast cancer cell lines under standard in vitro culture conditions and as a function of Epirubicin or Paclitaxel treatment. Moreover, we evaluated the expression in immunodeficient tumor mice as well as in humanized tumor mice (i.e., in the presence of a human immune system). We found highest PD-L1 levels in JIMT-1 and MDA-MB-231 cells. Epirubicin treatment caused a decrease and Paclitaxel treatment an increased PD-L1 expression in MDA-MB-231 cells. In addition, we identified nuclear PD-L1 in MDA-MB-231 cells. All in vivo transplanted breast cancer cell lines downregulated PD-L1 expression compared to their in vitro counterpart. Neither the gene copy number nor the presence of human immune system in humanized tumor mice had an effect on the PD-L1 content. We demonstrate that the degree of PD-L1 expression amongst breast cancer cell lines varies considerably. In addition, cytotoxic treatments and other extrinsic parameters differentially affect the expression. Hence, further investigations including in vivo evaluations are necessary to understand PD-L1 regulation for advanced breast cancer stratification. |
format | Online Article Text |
id | pubmed-5855785 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-58557852018-03-20 Regulation of Programmed Death Ligand 1 (PD-L1) Expression in Breast Cancer Cell Lines In Vitro and in Immunodeficient and Humanized Tumor Mice Rom-Jurek, Eva-Maria Kirchhammer, Nicole Ugocsai, Peter Ortmann, Olaf Wege, Anja K. Brockhoff, Gero Int J Mol Sci Article Programmed death ligand 1 (PD-L1) expression is an efficient strategy of tumor cells to escape immunological eradiation. However, only little is known about the factors that affect the cellular expression levels. Here we assessed the PD-L1 expression on different breast cancer cell lines under standard in vitro culture conditions and as a function of Epirubicin or Paclitaxel treatment. Moreover, we evaluated the expression in immunodeficient tumor mice as well as in humanized tumor mice (i.e., in the presence of a human immune system). We found highest PD-L1 levels in JIMT-1 and MDA-MB-231 cells. Epirubicin treatment caused a decrease and Paclitaxel treatment an increased PD-L1 expression in MDA-MB-231 cells. In addition, we identified nuclear PD-L1 in MDA-MB-231 cells. All in vivo transplanted breast cancer cell lines downregulated PD-L1 expression compared to their in vitro counterpart. Neither the gene copy number nor the presence of human immune system in humanized tumor mice had an effect on the PD-L1 content. We demonstrate that the degree of PD-L1 expression amongst breast cancer cell lines varies considerably. In addition, cytotoxic treatments and other extrinsic parameters differentially affect the expression. Hence, further investigations including in vivo evaluations are necessary to understand PD-L1 regulation for advanced breast cancer stratification. MDPI 2018-02-13 /pmc/articles/PMC5855785/ /pubmed/29438316 http://dx.doi.org/10.3390/ijms19020563 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Rom-Jurek, Eva-Maria Kirchhammer, Nicole Ugocsai, Peter Ortmann, Olaf Wege, Anja K. Brockhoff, Gero Regulation of Programmed Death Ligand 1 (PD-L1) Expression in Breast Cancer Cell Lines In Vitro and in Immunodeficient and Humanized Tumor Mice |
title | Regulation of Programmed Death Ligand 1 (PD-L1) Expression in Breast Cancer Cell Lines In Vitro and in Immunodeficient and Humanized Tumor Mice |
title_full | Regulation of Programmed Death Ligand 1 (PD-L1) Expression in Breast Cancer Cell Lines In Vitro and in Immunodeficient and Humanized Tumor Mice |
title_fullStr | Regulation of Programmed Death Ligand 1 (PD-L1) Expression in Breast Cancer Cell Lines In Vitro and in Immunodeficient and Humanized Tumor Mice |
title_full_unstemmed | Regulation of Programmed Death Ligand 1 (PD-L1) Expression in Breast Cancer Cell Lines In Vitro and in Immunodeficient and Humanized Tumor Mice |
title_short | Regulation of Programmed Death Ligand 1 (PD-L1) Expression in Breast Cancer Cell Lines In Vitro and in Immunodeficient and Humanized Tumor Mice |
title_sort | regulation of programmed death ligand 1 (pd-l1) expression in breast cancer cell lines in vitro and in immunodeficient and humanized tumor mice |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855785/ https://www.ncbi.nlm.nih.gov/pubmed/29438316 http://dx.doi.org/10.3390/ijms19020563 |
work_keys_str_mv | AT romjurekevamaria regulationofprogrammeddeathligand1pdl1expressioninbreastcancercelllinesinvitroandinimmunodeficientandhumanizedtumormice AT kirchhammernicole regulationofprogrammeddeathligand1pdl1expressioninbreastcancercelllinesinvitroandinimmunodeficientandhumanizedtumormice AT ugocsaipeter regulationofprogrammeddeathligand1pdl1expressioninbreastcancercelllinesinvitroandinimmunodeficientandhumanizedtumormice AT ortmannolaf regulationofprogrammeddeathligand1pdl1expressioninbreastcancercelllinesinvitroandinimmunodeficientandhumanizedtumormice AT wegeanjak regulationofprogrammeddeathligand1pdl1expressioninbreastcancercelllinesinvitroandinimmunodeficientandhumanizedtumormice AT brockhoffgero regulationofprogrammeddeathligand1pdl1expressioninbreastcancercelllinesinvitroandinimmunodeficientandhumanizedtumormice |